News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
628,263 Results
Type
Article (53651)
Company Profile (148)
Press Release (574464)
Multimedia
Podcasts (81)
Webinars (10)
Section
Business (170252)
Career Advice (3079)
Deals (30836)
Drug Delivery (112)
Drug Development (77504)
Employer Resources (175)
FDA (14936)
Job Trends (14304)
News (300222)
Policy (30349)
Tag
Academia (2863)
Academic (2)
Accelerated approval (4)
Adcomms (26)
Allergies (89)
Alliances (43616)
ALS (97)
Alzheimer's disease (1429)
Antibody-drug conjugate (ADC) (147)
Approvals (14935)
Artificial intelligence (272)
Autoimmune disease (24)
Automation (10)
Bankruptcy (275)
Best Places to Work (11638)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (107)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (299)
Cancer (2388)
Cardiovascular disease (184)
Career advice (2597)
Career pathing (34)
CAR-T (165)
Cell therapy (442)
Cervical cancer (22)
Clinical research (62862)
Collaboration (835)
Company closure (1)
Compensation (455)
Complete response letters (21)
COVID-19 (2758)
CRISPR (46)
C-suite (229)
Cystic fibrosis (98)
Data (2301)
Decentralized trials (2)
Denatured (14)
Depression (51)
Diabetes (275)
Diagnostics (6326)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (114)
Drug shortages (28)
Duchenne muscular dystrophy (99)
Earnings (69456)
Editorial (46)
Employer branding (23)
Employer resources (154)
Events (95825)
Executive appointments (663)
FDA (16287)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (723)
Gene editing (109)
Generative AI (28)
Gene therapy (338)
GLP-1 (765)
Government (4855)
Grass and pollen (5)
Guidances (157)
Healthcare (19084)
Huntington's disease (23)
IgA nephropathy (31)
Immunology and inflammation (130)
Indications (29)
Infectious disease (2912)
Inflammatory bowel disease (142)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (93)
Interviews (556)
IPO (15550)
IRA (43)
Job creations (3080)
Job search strategy (2147)
Kidney cancer (11)
Labor market (32)
Layoffs (468)
Leadership (24)
Legal (6596)
Liver cancer (80)
Lung cancer (340)
Lymphoma (159)
Machine learning (9)
Management (60)
Manufacturing (317)
MASH (77)
Medical device (12829)
Medtech (12833)
Mergers & acquisitions (15888)
Metabolic disorders (714)
Multiple sclerosis (85)
NASH (23)
Neurodegenerative disease (109)
Neuropsychiatric disorders (26)
Neuroscience (1996)
NextGen: Class of 2025 (6615)
Non-profit (4860)
Now hiring (21)
Obesity (367)
Opinion (267)
Ovarian cancer (82)
Pain (95)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (21)
Patents (229)
Patient recruitment (112)
Peanut (49)
People (47765)
Pharmaceutical (37)
Pharmacy benefit managers (19)
Phase I (19405)
Phase II (27707)
Phase III (21095)
Pipeline (1348)
Policy (159)
Postmarket research (2459)
Preclinical (8213)
Press Release (55)
Prostate cancer (109)
Psychedelics (30)
Radiopharmaceuticals (262)
Rare diseases (403)
Real estate (4979)
Recruiting (72)
Regulatory (21110)
Reports (39)
Research institute (2560)
Resumes & cover letters (518)
Rett syndrome (6)
RNA editing (4)
RSV (49)
Schizophrenia (75)
Series A (122)
Series B (77)
Service/supplier (6)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3156)
State (2)
Stomach cancer (12)
Supply chain (63)
Tariffs (50)
The Weekly (65)
Vaccines (771)
Venture capitalists (40)
Weight loss (250)
Women's health (32)
Worklife (20)
Date
Today (104)
Last 7 days (930)
Last 30 days (3085)
Last 365 days (30951)
2025 (11412)
2024 (33936)
2023 (39053)
2022 (49871)
2021 (54358)
2020 (53044)
2019 (47081)
2018 (35492)
2017 (30667)
2016 (29606)
2015 (33867)
2014 (25726)
2013 (21472)
2012 (22814)
2011 (23380)
2010 (21082)
Location
Africa (899)
Alabama (57)
Alaska (6)
Arizona (187)
Arkansas (13)
Asia (37643)
Australia (6561)
California (5907)
Canada (1951)
China (543)
Colorado (261)
Connecticut (268)
Delaware (158)
Europe (86472)
Florida (902)
Georgia (212)
Hawaii (1)
Idaho (52)
Illinois (525)
India (23)
Indiana (284)
Iowa (8)
Japan (158)
Kansas (101)
Kentucky (22)
Louisiana (7)
Maine (60)
Maryland (915)
Massachusetts (4447)
Michigan (187)
Minnesota (365)
Mississippi (2)
Missouri (78)
Montana (20)
Nebraska (24)
Nevada (57)
New Hampshire (60)
New Jersey (1713)
New Mexico (27)
New York (1721)
North Carolina (967)
North Dakota (6)
Northern California (2610)
Ohio (196)
Oklahoma (13)
Oregon (31)
Pennsylvania (1270)
Puerto Rico (11)
Rhode Island (27)
South America (1207)
South Carolina (25)
South Dakota (1)
Southern California (2256)
Tennessee (103)
Texas (879)
United States (22434)
Utah (174)
Virginia (148)
Washington D.C. (63)
Washington State (510)
West Virginia (3)
Wisconsin (52)
628,263 Results for "national institute on aging".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
Pharm Country
NYU Langone Health’s New Optimal Aging Institute to Further Explore the Link Between Vascular Health and Aging
Researchers at the newly-formed Optimal Aging Institute at NYU Langone Health have been awarded $31 million by the National Institutes of Health for a diverse, ten university cohort to study how vascular risk factors contribute to dementia and other age-related disorders in those over the age of 85, building upon existing research.
April 11, 2024
·
6 min read
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Pharmacy benefit managers
Trump’s Most Favored Nations Policy Sparks PBM Selloff
The Most Favored Nations directive would allow drugmakers to directly sell their products to patients at a lower cost, cutting out what President Donald Trump called “the middlemen.”
May 13, 2025
·
2 min read
·
Tristan Manalac
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Genetown
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell
BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell.
March 7, 2024
·
4 min read
Press Releases
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
January 7, 2025
·
3 min read
Press Releases
Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
January 23, 2025
·
10 min read
Press Releases
Wolters Kluwer Empowers Medical Research in India with Ovid as part of One Nation One Subscription (ONOS)
April 24, 2025
·
2 min read
1 of 62,827
Next
